Cite
Sheetz T, Mills J, Tessari A, et al. NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs. Cancers (Basel). 2020;12(7)doi: 10.3390/cancers12071861.
Sheetz, T., Mills, J., Tessari, A., Pawlikowski, M., Braddom, A. E., Posid, T., Zynger, D. L., James, C., Embrione, V., Parbhoo, K., Foray, C., Coppola, V., Croce, C. M., & Palmieri, D. (2020). NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs. Cancers, 12(7), . https://doi.org/10.3390/cancers12071861
Sheetz, Tyler, et al. "NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs." Cancers vol. 12,7 (2020). doi: https://doi.org/10.3390/cancers12071861
Sheetz T, Mills J, Tessari A, Pawlikowski M, Braddom AE, Posid T, Zynger DL, James C, Embrione V, Parbhoo K, Foray C, Coppola V, Croce CM, Palmieri D. NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs. Cancers (Basel). 2020 Jul 10;12(7). doi: 10.3390/cancers12071861. PMID: 32664322; PMCID: PMC7408652.
Copy
Download .nbib